What is STRATA Skin Sciences?
STRATA Skin Sciences operates as a specialized medical technology entity focused on the dermatology sector. The company is primarily recognized for the development, commercialization, and marketing of proprietary systems, including the XTRAC and Pharos excimer lasers, as well as VTRAC lamp systems. These technologies are engineered to address chronic dermatologic conditions such as psoriasis and vitiligo, positioning the company as a critical provider of clinical-grade, in-office therapeutic hardware. By integrating advanced light-based technology into dermatological practice, STRATA Skin Sciences bridges the gap between complex medical engineering and patient-centric care.
How much funding has STRATA Skin Sciences raised?
STRATA Skin Sciences has raised a total of $245.8M across 17 funding rounds:
Stock Offering
$16.3M
Stock Offering
$7.3M
Stock Offering
$6M
Debt
$12.4M
Other Financing Round
$27.3M
Debt
$10M
Private Equity
$17M
Debt
$2M
Debt
$7M
Stock Issuance/Offering (2011): $16.3M featuring Undisclosed
Stock Issuance/Offering (2013): $7.3M backed by Undisclosed
Stock Issuance/Offering (2013): $6M with participation from Undisclosed
Debt (2014): $12.5M led by Sabby Management
Other Financing Round (2014): $27.3M supported by Sabby Management, Great Point Partners, and Broadfin Capital
Debt (2016): $10M featuring MidCap Financial Trust
Private Equity (2018): $17M backed by Sabby Management, Dr. Dolev Rafeli, Accelmed Growth Partners, and Broadfin Capital
Debt (2020): $2M with participation from PPP
Debt (2023): $7M led by MidCap Financial
Key Investors in STRATA Skin Sciences
Great Point Partners
A leading health care investment firm that provides growth equity and management buyout financing to companies across the biopharmaceutical and medical technology sectors.
Broadfin Capital
A healthcare-focused investment firm that specializes in unique opportunities within the sector, offering comprehensive financial strategies and asset allocation services.
MidCap Financial
A financial services provider that delivers flexible, efficient debt financing solutions tailored to the specific needs of growing companies.
What's next for STRATA Skin Sciences?
The recent infusion of $7M serves as a strategic catalyst for the company's ongoing operational scaling. Given the firm's established history of utilizing debt and equity financing to bolster its market position, this latest capital injection is expected to support the expansion of its commercial footprint and the continued refinement of its laser-based product pipeline. As the company navigates the evolving landscape of medical device regulation and clinical adoption, the focus remains on optimizing the utilization of its core assets to drive long-term value in the competitive dermatology market.
See full STRATA Skin Sciences company page
